JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

Search

West Pharmaceutical Services Inc

Fechado

SetorSaúde

238.93 -1.42

Visão Geral

Variação de preço das ações

24h

Atual

Mín

239.48

Máximo

242.02

Indicadores-chave

By Trading Economics

Rendimento

42M

132M

Vendas

69M

767M

P/E

Médio do Setor

35.848

34.393

EPS

1.45

Rendimento de Dividendos

0.35

Margem de lucro

17.195

Funcionários

10,600

EBITDA

48M

199M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+29.93% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.35%

2.54%

Próximos Ganhos

23 de out. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

2B

17B

Abertura anterior

240.35

Fecho anterior

238.93

Sentimento de Notícias

By Acuity

50%

50%

162 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

West Pharmaceutical Services Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de ago. de 2025, 17:49 UTC

Grandes Movimentos do Mercado

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11 de ago. de 2025, 17:18 UTC

Grandes Movimentos do Mercado

Tiziana Life Sciences Rises After FDA Approves IND for Foralumab Trial

11 de ago. de 2025, 16:25 UTC

Ganhos

Correction to Constellation Software 2Q Revenue Rises, Profit Shrinks Article on Aug. 8

11 de ago. de 2025, 23:50 UTC

Conversa de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

11 de ago. de 2025, 23:42 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

11 de ago. de 2025, 23:42 UTC

Conversa de Mercado

Woodside's Share Price Implies Lofty Oil Price -- Market Talk

11 de ago. de 2025, 23:36 UTC

Conversa de Mercado

Gold Edges Higher on Likely Technical Recovery -- Market Talk

11 de ago. de 2025, 23:32 UTC

Conversa de Mercado

Argosy's New Bull Sees Sentiment Toward REITs Improving -- Market Talk

11 de ago. de 2025, 23:02 UTC

Conversa de Mercado

RBA Set to Lower OCR With New Forecasts in Focus -- Market Talk

11 de ago. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

11 de ago. de 2025, 20:37 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Bakkt Holdings: Andy Main Will Step Dn as Co-CEO and Director, Effective Aug 11, and Akshay Naheta Will Assume Role of CEO >BKKT

11 de ago. de 2025, 20:37 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Bakkt Holdings 2Q Rev $577.9M >BKKT

11 de ago. de 2025, 20:37 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Bakkt Holdings: In Upcoming Qtr, Will Conduct Comprehensive Review of Cost Structure to Ensure We Are Optimized, Driving Synergies Across Business, and Accelerating Path to Profitability >BKKT

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement: Assets 2,058 Units of Bitcoin Valued at $220.5M, 2,729 Units of Ether Valued at $6.8M, $58.1M in Cash and Cash Equivalents, USD Coin, Treasury Bills as of June 30 >EXOD

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement: Monthly Active Users 1.5M at End 2Q, Unchanged From 1.5M as of June 30, 2024 >EXOD

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement: Processed Volume $1.38B in 2Q Dn 37% From 1Q, Bitcoin, Tether (TRX Network), Tether (ETH Network), USDC, SOL Top Assets Traded in 2Q >EXOD

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement: Digital Assets and Liquid Assets $291.2M >EXOD

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement 2Q Rev $25.8M >EXOD

11 de ago. de 2025, 20:14 UTC

Conversa de Mercado

Canada Dollar Faces Near-Term Weakness on Trade Row, September Rate-Cut Chatter -- Market Talk

11 de ago. de 2025, 19:12 UTC

Conversa de Mercado

Crude-Oil Futures Edge Up in Rangebound Trade -- Market Talk

11 de ago. de 2025, 18:56 UTC

Conversa de Mercado

U.S. Natural-Gas Futures Fall on Forecast Loss of Late August Heat -- Market Talk

11 de ago. de 2025, 18:31 UTC

Conversa de Mercado

Mining Halt Could Lift Lithium Prices in Near Term -- Market Talk

11 de ago. de 2025, 17:43 UTC

Conversa de Mercado

Freeport-McMoRan Can Push Up Prices, Profits With Copper Tariff Protection -- Market Talk

11 de ago. de 2025, 17:28 UTC

Conversa de Mercado

Crossborder Trade Tensions Accelerate Softness in Canada Rents -- Market Talk

11 de ago. de 2025, 17:16 UTC

Conversa de Mercado

Commodity Longs Fall to 11-Month Low -- Market Talk

11 de ago. de 2025, 16:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Adobe Stock Gets a Downgrade. 'AI Is Eating Software,' Analyst Says. -- Barrons.com

11 de ago. de 2025, 16:27 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA Says Sabadell Offer Remains in Effect

11 de ago. de 2025, 16:26 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA Previously Said It Won't Withdraw Offer to Buy Sabadell

11 de ago. de 2025, 16:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Banco de Sabadell Announced TSB Sale on July 1

11 de ago. de 2025, 16:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Banco de Sabadell Shareholders Approved TSB Unit Sale on Aug 6

Comparação entre Pares

Variação de preço

West Pharmaceutical Services Inc Previsão

Preço-alvo

By TipRanks

29.93% parte superior

Previsão para 12 meses

Média 313.11 USD  29.93%

Máximo 350 USD

Mínimo 245 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para West Pharmaceutical Services Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

10 ratings

9

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

213.26 / 219.27Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

162 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.